2
Installation with Pop-up Café at the Kunstmuseum St.Gallen | Thi My Lien Nguyen: Shaping Fluidity
Un document
plus
Actualités de Rapperswil
Hostpoint launches free service for migrating web hosting, domains and e-mail
plusHostpoint remains on course for very good growth in 2023
plusHostpoint now accepting registration applications for .swiss domains from private individuals
plusHostpoint looks back on a successful 2022 with a milestone of one million domains
plus- 5
Hostpoint launches new e-mail offering with comprehensive office and team functions
plus - 2
Alexander Hahn: Memory of Light – Light of Memory, 29 October 2022 – 2 April 2023, Kunstmuseum St.Gallen
Un documentplus Hostpoint achieves record growth once again in its anniversary year 2021
plusHostpoint is the first Swiss provider to offer telephone support on weekends
plusHostpoint is now accepting applications to register .zuerich domains for businesses in the Zurich region
plusHostpoint activates DNSSEC for .ch and .li domains to improve internet security in Switzerland
plus- 5
Hostpoint celebrates its 20th anniversary and looks back on a successful history
plus Hostpoint speeds up access to websites around the globe with DNS Anycast
plus- 3
Hostpoint solidifies its position as the largest web hosting provider in Switzerland
plus Hostpoint now offers protection against domain loss
plusHostpoint enables parallel operation of Nginx and Apache in shared hosting
plusHostpoint now supports DNSSEC and DANE
plusFree video conferences on secure Swiss servers with "Hostpoint Meet"
plusHostpoint launches its new "Webshop" e-commerce solution
plusHostpoint continues on a strong growth course
plusHostpoint becomes first Swiss web hosting provider to use WhatsApp for customer service
plusSo that all mothers and fathers can sleep better: The digital pacifier for quieter nights
plusHostpoint launches flexible managed server solution for SMEs and web agencies
plusHostpoint exceeds CHF 20 million in turnover
plus- 2
Neovii Pharmaceuticals AG announces new CEO
plus Long-term outcomes after standard graft-versus-host disease (GvHD) prophylaxis in hemopoietic cell transplantation from matched unrelated donors strongly support the use of Grafalon® as standard therapy
plus
1